AstraZeneca Pharma India, on Tuesday, said it will de-list itself from domestic stock exchanges, fueling a jump of 20 per cent in its stock price to hit its all time high at Rs 1,207.05.

The company's board of directors gave its nod for making a voluntary delisting offer, received from its Sweden..